News

SPERA PHARMA will be exhibiting at INTERPHEX 2025 which will be held at Tokyo Big Sight from July 9th to 11th, 2025. This is a joint exhibition with Iwaki Seiyaku Sakura Factory Co., Ltd., part of the Astena G...

We are pleased to announce that Dr. Atsushi Kaga from our Chemical R&D Laboratory has been invited to speak at the 1st Sino-Japanese Symposium on Process Chemistry (SJPC2025), which will be held in June 20...

A new research paper by Keiyo Nakai, et al. has been published in the academic journal "Molecular Pharmaceutics" of the American Chemical Society.   掲載誌: 　   Molecular Pharmaceutics, 2025, 22, 5...

SPERA PHARMA will be exhibiting at Chemspec Europe, held at Koelnmesse in  Germany from June 4th to 5th, 2025.   ★Chemspec Europe★ 　　   Date: June 4th-5th, 2025 　　　Venue: Koelnmesse, Germany ...

PDF download SPERA PHARMA, Inc. (headquarters: Osaka; President & Representative Director: Keitaro Iwaki; hereinafter “SPERA PHARMA”) and Rigaku Corporation, a Group company of Rigaku Holdings Corporation...

SPERA PHARMA will be exhibiting at CPHI Japan 2025 which will be held at Tokyo Big Sight from April 9th to 11th, 2025. SPERA NEXUS, Inc., part of Astena Group and engaged in the fine chemicals business, will a...

A new research paper by Dr. Keiyo Nakai et al. has been published in the academic journal "Crystal Growth & Design of the American Chemical Society.   Journal: 　      Crystal Growth & Desig...

At SPERA PHARMA, we have added the latest 3D ED/MicroED (Three-Dimensional Electron Diffraction/Microcrystal Electron Diffraction) to our conventional X-ray analysis lineup, paving the way for a new chapter in...